Neuphoria Therapeutics (NEUP) Return on Invested Capital (2024 - 2026)
Neuphoria Therapeutics (NEUP) reported Return on Invested Capital of 0.01% for Q1 2026, down 1.0% year-over-year from 0.01% in Q1 2025, and down 241.42% on a QoQ basis from 0.0% in Q4 2025.
Neuphoria Therapeutics (NEUP) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Invested Capital fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital eased to 0.01% in Q1 2026 per NEUP's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q1 2025 and bottomed at 0.01% in Q1 2026.
- The 3-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.0%.
- The widest annual swing landed in 2025, when Return on Invested Capital changed 0 bps; it then fell 1 bps in 2026.
- Tracing NEUP's Return on Invested Capital over 3 years: stood at 0.0% in 2024, then sank by 120 bps to 0.0% in 2025, then slumped by 241 bps to 0.01% in 2026.
- Per Business Quant, the three latest NEUP Return on Invested Capital figures stand at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.01% |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |